SlideShare a Scribd company logo
PSYCHIATRIC
DISORDER
Mr. Kiran B. Dhamak
Introduction
 Many people have mental health concerns
from time to time.
 But a mental health concern becomes a
mental illness when ongoing signs and
symptoms cause frequent stress and affect
your ability to function.
 A mental illness can make you miserable and
can cause problems in your daily life, such as
at school or work or in relationships.
 In most cases, symptoms can be managed
with a combination of medications and talk
therapy (psychotherapy).
Symptoms
 Feeling sad or down
 Confused thinking or
reduced ability to
concentrate
 Excessive fears or worries,
or extreme feelings of guilt
 Extreme mood changes of
highs and lows
 Withdrawal from friends and
activities
 Significant tiredness, low
energy or problems sleeping
 Detachment from reality
(delusions), paranoia or
hallucinations
 Inability to cope with
daily problems or stress
 Trouble understanding
and relating to situations
and to people
 Problems with alcohol or
drug use
 Major changes in eating
habits
 Sex drive changes
 Excessive anger, hostility
or violence
 Suicidal thinking
Types of Psychiatric Disorders
 Depression
 Anxiety
 Psychosis
 A psychiatric disorder is a mental illness refers
to a broad range of problems that disturb
person's thoughts, feelings, behavior or mood.
 It can significantly affect a person's ability to
perform at work or school, or maintain healthy
social relationships.
 Psychiatric disorders are treatable.
 Examples of psychiatric disorders are:
 (1) Major depressive disorder (Depression)
which is characterized by persistent low
moods and loss of energy and enthusiasm.
 (2) Generalized anxiety disorder (Anxiety)
which is characterized by excessive,
persistent, unrealistic worry about everyday
things.
 (3) Psychosis which is characterized by a
disconnection from reality (may have
hallucinations or delusions).
 (4) Post-traumatic stress disorder which is
characterized by intense, disturbing thoughts
and feelings related to a traumatic experience
long after the experience is over.
 (5) Bipolar disorder which is characterized by
extreme shifts in mood, energy, and activity
level.
DEPRESSION
 Depression, also known as major depressive
disorder (MDD) or clinical depression is
achronic episodic and relapsing mood disorder
primarily characterized by depressed or sad
mood and anhedonia lasting for at least 2
weeks.
 Anhedonia is an inability to feel pleasure
normally pleasurable activities MDD can cause
significant distress and impairment is leading
cause of suicide Occurrence of MDD in
females is almost twice than in males There
are various subtypes of MDD characterized by
additional symptoms or occurrenc in
 (a) Atypical depression additionally
characterized by weight gain and increase
appetite
 (b) Psychotic depression with additional
psychotic features such as hallucinations an
delusions
 (c) Peripartum depression which occurs during
or shortly after pregnancy.
Etiopathogenesis of Depression
 The etiology of depression is very complex. It
includes both biological and psychological factors.
 Decreased levels of monoamine
neurotransmitters (serotonin, noradrenaline,
dopamine) are believed to be the
pathophysiological basis in most cases.
 Psychological factors such as traumatic and
stressful experiences and comorbidities like
neurodegenerative and chronic inflammatory
diseases also play important role in developing
depression.
 Complications of depression include self-
Clinical Manifestations of
Depression
 Depression symptoms can vary from mild to
severe and can include: sad mood, a feeling of
deep sadness (melancholia), anhedonia, low
energy, worthlessness, guilt, psychomotor
retardation or agitation, change in appetite
and/or sleep, increase in purposeless physical
activity (e.g, hand-wringing or pacing) or
slowed movements and speech, suicidal
thoughts etc.
 In elderly patients, memory loss and other
symptoms seen in dementia may be there.
Diagnosis and Investigation of
Depression
 First of all, rule out medical causes of
depression and drug induced depression.
Follow the DSM-5 criteria to make a diagnosis
of depression DSM-5 is Diagnosis Statistical
Manual of Mental Disorders, 5 Ed. Available at
 https://psychiatry.org/psychiatrists/practice/ds
m Use screening tools
 eg. Patient Health Questionnaire PHQ9, PHQ2
Management of Depression
 Goals of Therapy
 1. Resolution of all signs and symptoms of
depression (i.e, remission) and restoration of
functioning
 Reduction of further episodes of depression (ie,
relapse or recurrence).
 Prevention of occurrence of new episode of
depression and suicide.
 Resolving residual symptoms (eg, fatigue,
cognitive impairment, anhedonia, anxiety).
 Restoration of occupational, psychosocial and
interpersonal function
Treatment Modalities Available:
 1. Psychotherapy alone
 2. Pharmacotherapy alone
 3. Psychotherapy combined with pharmacological
therapy
Selection of treatment modality is based on
following factors
 1. Severity of symptoms (mild, moderate or
severe)
 2. Presence of other diseases (comorbidities) or
psychosocial stressors
 3. Preference of patient
 4. History of prior treatment
 Psychotherapy or pharmacological therapy
may be used alone if patient has mild to
moderate depression.
 Psychotherapy combined with
pharmacological therapy may be useful for
patients with moderate to severe depression.
Non-Pharmacological Management of
Depression
 Psychotherapy
 Psychotherapy is the initial choice of treatment
for mild to moderate depression.
 It is also he treatment of choice for pregnant
patients or those who desire pregnancy. It is
given in combination with antidepressants in
patients who have moderate to severe
depression.
 Types of psychotherapy include:
(a) Cognitive behavioral therapy
(CBT)
(b) Interpersonal therapy
(c) Psychodynamic psychotherapy
(d) Family and couples therapy
 (a) Cognitive-Behavioral Therapy (CBT):
Cognitive behavioral therapy helps the patient
to recognize negative or unhelpful thought and
behavior patterns. It promotes self control over
thinking patterns.
 (b) Interpersonal Therapy (IPT):
Interpersonal therapy aims at resolving
interpersonal problems (eg, social isolation,
prolonged grief, reducing stress involving
family and work, improving communication
skills and symptomatic recovery.
 (c) Psychodynamic Psychotherapy:
Psychodynamic psychotherapy aims at
promoting personality change through
understanding of major conflicts, ego
distortions providing role model, permitting
emotional release of aggression.
 (d) Family and Couples Therapy: It is
considered for patients with significant marital
or family distress
Pharmacological managements
 1. The goal of pharmacotherapy of depression
is the resolution of current symptoms
(ie.remission) and the prevention of further
episodes of depression (ie. relapse or
recurrence)
 2. Selection of antidepressant drugs will be
based on side effect profile, prior respons
history of patient or family member presence
of comorbidities, concurrent medication risk of
death from overdose and patient preference
and cost.
 3. Patients should be informed that adverse
effects might occur immediately, whereas
resolution of symptoms can take 2 to 4 weeks
or longer. If side effects occur, eithe decrease
the dose of the drug or shift to another
antidepressant which does not cause the
same adverse effect.
 4. Always start with the lowest dose of drug
and increase in small steps to full therapeutic
dose.
 5. It is recommended that antidepressant dose
be increased in patients who non-improvers
Classification of
Antidepressants
 Selective serotonin reuptake inhibitors
(SSRIs). Health care providers often start by
prescribing an SSRI. These antidepressants
generally cause fewer bothersome side effects
and are less likely to cause problems at higher
therapeutic doses than other types of
antidepressants. SSRIs include
 fluoxetine (Prozac),
 paroxetine (Paxil, Pexeva),
 sertraline (Zoloft),
 citalopram (Celexa) and
 escitalopram (Lexapro).
 Serotonin and norepinephrine reuptake
inhibitors (SNRIs). Examples
of SNRIs include
 duloxetine (Cymbalta, Drizalma Sprinkle),
 venlafaxine (Effexor XR),
 desvenlafaxine (Pristiq) and
 levomilnacipran (Fetzima).
 Atypical antidepressants. These
antidepressants are called atypical because
they don't fit neatly into any of the other
antidepressant categories. More-commonly
prescribed antidepressants in this category
include trazodone, mirtazapine (Remeron),
vortioxetine (Trintellix), vilazodone (Viibryd)
and bupropion (Forfivo XL, Wellbutrin SR,
others). Bupropion is one of the few
antidepressants not frequently associated with
sexual side effects.
 Tricyclic antidepressants. Tricyclic
antidepressants — such as imipramine,
nortriptyline (Pamelor), amitriptyline, doxepin
and desipramine (Norpramin) — tend to cause
more side effects than newer antidepressants.
So tricyclic antidepressants generally aren't
prescribed unless you've tried other
antidepressants first without improvement.
 Monoamine oxidase inhibitors
(MAOIs). MAOIs — such as tranylcypromine
(Parnate), phenelzine (Nardil) and isocarboxazid
(Marplan) — may be prescribed, often when
other medicines haven't worked. This is because
they can have serious side effects. Using
an MAOI requires a strict diet because of
dangerous (or even deadly) interactions with
foods that contain tyramine — such as certain
cheeses, pickles and wines — and some
medicines, including pain medicines,
decongestants and certain herbal supplements.
Selegiline (Emsam), an MAOI that you stick on
your skin as a patch, may cause fewer side
 Other medications. Your health care provider
may recommend combining two
antidepressants. Or your provider may add
other medicines to improve antidepressant
effects. This is called augmentation. Examples
of antidepressant augmentation medicines
include aripiprazole (Abilify), quetiapine
(Seroquel) and lithium (Lithobid).
Anxiety
 The term anxiety has been used for decades
to refer to thoughts and behaviours that were
distressful in nature.
 But before they referred to these as “anxiety
disorders”, they are called “neurosis” which
means nervousness that was not based in
fact.
 Anxiety can be described as a feeling of alarm
or worry. It may be about something specific or
it may be non-specific in nature.
 At certain level it improves our performance
and allow people to avoid dangerous
 This normally lasts for a short period causing
no impairment in social or occupational
functioning.
 When this anxiety is prolonged and affects
social or occupational functioning, it is
abnormal and accounts for anxiety “disorder”.
Etiopathogenesis
 Anxiety is of a greater degree than just everyday
worries and patients do mention that they are not
able to control these worries. They are frequently
accompanied with physical symptoms as well.
These symptoms have to present for most days at
least for several weeks at a time.
 Patients often experience a state of intense
apprehension, uncertainty, and fear resulting from
the anticipation of a threatening event or situation,
often to a degree that normal physical and
psychological functioning is disrupted. This may be
precipitated due to several reasons which are
generally easily identified by patient himself.
Clinical manifestations
 Feelings that something undesirable.
 Dry mouth, swallowing difficulty, hoarseness.
 Rapid breathing and heartbeat, palpitations.
 Twitching or trembling.
 Muscle tension headaches backache.
 Dizziness or faintness.
 Difficulty in concentrating.
 Nausea, diarrhoea, weight loss.
 Memory problems and difficulty in concentrating.
 Sweating, fatigue, irritability.
 Sleeplessness and nightmare.
Non-pharmacological
managements
 Follow the diet rules and pattern because any
disturbance in the digestive activity leads to the
mental manifestations.
 Visit the religious and graceful places and try to
spending much time on that place.
 Avoid the over thinking and bad habits and try to
always indulges with your own work, which makes
you pleasant.
 Regular practice of yoga and meditation it is the
most important factor for managing the psychiatric
disorders.
 Multimedia, internet etc. are one among the cause
of the psychiatric disorder, so try to use those
such things with proper time and need.
Pharmacological Management of
Anxiety
 Selective serotonin reuptake inhibitors
(SSRIs). Health care providers often start by
prescribing an SSRI. These antidepressants
generally cause fewer bothersome side effects
and are less likely to cause problems at higher
therapeutic doses than other types of
antidepressants. SSRIs include
 fluoxetine (Prozac),
 paroxetine (Paxil, Pexeva),
 sertraline (Zoloft),
 citalopram (Celexa) and
 escitalopram (Lexapro).
 Serotonin and norepinephrine reuptake
inhibitors (SNRIs). Examples
of SNRIs include
 duloxetine (Cymbalta, Drizalma Sprinkle),
 venlafaxine (Effexor XR),
 desvenlafaxine (Pristiq) and
 levomilnacipran (Fetzima).
Psychosis
 Psychosis and the specific diagnosis of
schizophrenia represent a major psychiatric
disorder (or cluster of disorders) in which a
person’s perceptions, thoughts, mood and
behaviour are significantly altered.
 Psychosis is a common and functionally
disruptive symptom of many psychiatric,
neurodevelopmental, neurologic, and medical
conditions and an important target of
evaluation and treatment in neurologic and
psychiatric practice.
Etiopathogenesis
 A psychotic episode or disorder will result in
the presence of one or more of the following
five categories: delusions, hallucinations,
disorganized thought, disorganized behaviour,
negative symptoms.
 Some common causes similar to the anxiety
but is also induced as-
 Genetic/heredity.
 Chemical imbalances.
Clinical manifestations
 Unusual and extremely slowed movements.
 Incoherent or disorganized speaking.
 Hallucinations, usually related to hearing
voices or strange sounds.
 Delusions
 Isolating behaviour.
 Feeling suspicious paranoid or afraid.
 Not caring about their hygiene and
appearance.
 Depression anxiety and suicidal thought.
Non-pharmacological
managements.
 Follow the diet rules and pattern because any
disturbance in the digestive activity leads to the
mental manifestations.
 Visit the religious and graceful places and try to
spending much time on that place.
 Avoid the over thinking and bad habits and try to
always indulges with your own work, which makes
you pleasant.
 Multimedia, internet etc. are one among the cause
of the psychiatric disorder, so try to use those
such things with proper time and need.
 Regular practice of yoga and meditation it is the
most important factor for managing the psychiatric
disorders.
Pharmacological managements
Psychiatric_Disorder.pptx

More Related Content

Similar to Psychiatric_Disorder.pptx

Depression Clinical pharmacology
Depression Clinical pharmacologyDepression Clinical pharmacology
Depression Clinical pharmacology
Saikrishna Komaragiri
 
How Is Depression Distinct from Anxiety?
How Is Depression Distinct from Anxiety?How Is Depression Distinct from Anxiety?
How Is Depression Distinct from Anxiety?
Athena Behavioral Health
 
Antidepressant
AntidepressantAntidepressant
Antidepressant
Pabitra Thapa
 
mood_disorders-61236543y7776543279998654
mood_disorders-61236543y7776543279998654mood_disorders-61236543y7776543279998654
mood_disorders-61236543y7776543279998654
MaryemSafdar2
 
Mood Disorder and Suicide
Mood Disorder and SuicideMood Disorder and Suicide
Mood Disorder and Suicide
jumar ubalde
 
Depressive disorders
Depressive disordersDepressive disorders
Depressive disorders
bhavik chheda
 
Unipolar Depression .ppt
Unipolar Depression .pptUnipolar Depression .ppt
Unipolar Depression .ppt
ssuserbf570f
 
Unit 4
Unit 4Unit 4
Unit 4
c.meza
 
SOROTI UNIVERSITY.pptx
SOROTI UNIVERSITY.pptxSOROTI UNIVERSITY.pptx
SOROTI UNIVERSITY.pptx
1901600146
 
Depression
DepressionDepression
Depression
MichaelJoseph167
 
MHN (pritesh )depression
MHN (pritesh )depressionMHN (pritesh )depression
MHN (pritesh )depression
Pritesh Patel
 
Depression and Antidepressant By Muhammad Kamal Hossain.pptx
Depression and Antidepressant By Muhammad Kamal Hossain.pptxDepression and Antidepressant By Muhammad Kamal Hossain.pptx
Depression and Antidepressant By Muhammad Kamal Hossain.pptx
Muhammad Kamal Hossain
 
Depression 1.pptx
Depression 1.pptxDepression 1.pptx
Depression 1.pptx
Abdirahmaan6
 
Depressive disorder ppt presentation
Depressive disorder ppt presentationDepressive disorder ppt presentation
Depressive disorder ppt presentation
2203538
 
Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)
Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)
Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)
College of Medicine, Sulaymaniyah
 
DEPRESSION MANAGEMENT & SUICIDE(AUG 2021).ppt
DEPRESSION MANAGEMENT & SUICIDE(AUG 2021).pptDEPRESSION MANAGEMENT & SUICIDE(AUG 2021).ppt
DEPRESSION MANAGEMENT & SUICIDE(AUG 2021).ppt
FREDRICK70
 
An Overview Of Depression
An Overview Of DepressionAn Overview Of Depression
An Overview Of Depression
Mpmacolorado
 
the-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdfthe-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdf
PiyushSharma12895
 
the-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdfthe-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdf
PiyushSharma358470
 

Similar to Psychiatric_Disorder.pptx (20)

Depression Clinical pharmacology
Depression Clinical pharmacologyDepression Clinical pharmacology
Depression Clinical pharmacology
 
How Is Depression Distinct from Anxiety?
How Is Depression Distinct from Anxiety?How Is Depression Distinct from Anxiety?
How Is Depression Distinct from Anxiety?
 
Mood Disorders
Mood DisordersMood Disorders
Mood Disorders
 
Antidepressant
AntidepressantAntidepressant
Antidepressant
 
mood_disorders-61236543y7776543279998654
mood_disorders-61236543y7776543279998654mood_disorders-61236543y7776543279998654
mood_disorders-61236543y7776543279998654
 
Mood Disorder and Suicide
Mood Disorder and SuicideMood Disorder and Suicide
Mood Disorder and Suicide
 
Depressive disorders
Depressive disordersDepressive disorders
Depressive disorders
 
Unipolar Depression .ppt
Unipolar Depression .pptUnipolar Depression .ppt
Unipolar Depression .ppt
 
Unit 4
Unit 4Unit 4
Unit 4
 
SOROTI UNIVERSITY.pptx
SOROTI UNIVERSITY.pptxSOROTI UNIVERSITY.pptx
SOROTI UNIVERSITY.pptx
 
Depression
DepressionDepression
Depression
 
MHN (pritesh )depression
MHN (pritesh )depressionMHN (pritesh )depression
MHN (pritesh )depression
 
Depression and Antidepressant By Muhammad Kamal Hossain.pptx
Depression and Antidepressant By Muhammad Kamal Hossain.pptxDepression and Antidepressant By Muhammad Kamal Hossain.pptx
Depression and Antidepressant By Muhammad Kamal Hossain.pptx
 
Depression 1.pptx
Depression 1.pptxDepression 1.pptx
Depression 1.pptx
 
Depressive disorder ppt presentation
Depressive disorder ppt presentationDepressive disorder ppt presentation
Depressive disorder ppt presentation
 
Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)
Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)
Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)
 
DEPRESSION MANAGEMENT & SUICIDE(AUG 2021).ppt
DEPRESSION MANAGEMENT & SUICIDE(AUG 2021).pptDEPRESSION MANAGEMENT & SUICIDE(AUG 2021).ppt
DEPRESSION MANAGEMENT & SUICIDE(AUG 2021).ppt
 
An Overview Of Depression
An Overview Of DepressionAn Overview Of Depression
An Overview Of Depression
 
the-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdfthe-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdf
 
the-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdfthe-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdf
 

More from Dr. Kiran Dhamak

Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Dr. Kiran Dhamak
 
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Dr. Kiran Dhamak
 
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. PharmCardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Dr. Kiran Dhamak
 
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in PharmacyDermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dr. Kiran Dhamak
 
3.3 Antimicrobial Agents.pptx
3.3 Antimicrobial Agents.pptx3.3 Antimicrobial Agents.pptx
3.3 Antimicrobial Agents.pptx
Dr. Kiran Dhamak
 
3.4 Dental products.pptx
3.4 Dental products.pptx3.4 Dental products.pptx
3.4 Dental products.pptx
Dr. Kiran Dhamak
 
3.2 Antacids.pptx
3.2 Antacids.pptx3.2 Antacids.pptx
3.2 Antacids.pptx
Dr. Kiran Dhamak
 
3.1 Haematinics.pptx
3.1 Haematinics.pptx3.1 Haematinics.pptx
3.1 Haematinics.pptx
Dr. Kiran Dhamak
 
4. Heterocyclic_Compounds.pptx
4. Heterocyclic_Compounds.pptx4. Heterocyclic_Compounds.pptx
4. Heterocyclic_Compounds.pptx
Dr. Kiran Dhamak
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptx
Dr. Kiran Dhamak
 
Introduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptxIntroduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptx
Dr. Kiran Dhamak
 

More from Dr. Kiran Dhamak (11)

Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
 
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
 
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. PharmCardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
 
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in PharmacyDermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
 
3.3 Antimicrobial Agents.pptx
3.3 Antimicrobial Agents.pptx3.3 Antimicrobial Agents.pptx
3.3 Antimicrobial Agents.pptx
 
3.4 Dental products.pptx
3.4 Dental products.pptx3.4 Dental products.pptx
3.4 Dental products.pptx
 
3.2 Antacids.pptx
3.2 Antacids.pptx3.2 Antacids.pptx
3.2 Antacids.pptx
 
3.1 Haematinics.pptx
3.1 Haematinics.pptx3.1 Haematinics.pptx
3.1 Haematinics.pptx
 
4. Heterocyclic_Compounds.pptx
4. Heterocyclic_Compounds.pptx4. Heterocyclic_Compounds.pptx
4. Heterocyclic_Compounds.pptx
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptx
 
Introduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptxIntroduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptx
 

Recently uploaded

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 

Recently uploaded (20)

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 

Psychiatric_Disorder.pptx

  • 2.
  • 3. Introduction  Many people have mental health concerns from time to time.  But a mental health concern becomes a mental illness when ongoing signs and symptoms cause frequent stress and affect your ability to function.  A mental illness can make you miserable and can cause problems in your daily life, such as at school or work or in relationships.  In most cases, symptoms can be managed with a combination of medications and talk therapy (psychotherapy).
  • 4. Symptoms  Feeling sad or down  Confused thinking or reduced ability to concentrate  Excessive fears or worries, or extreme feelings of guilt  Extreme mood changes of highs and lows  Withdrawal from friends and activities  Significant tiredness, low energy or problems sleeping  Detachment from reality (delusions), paranoia or hallucinations  Inability to cope with daily problems or stress  Trouble understanding and relating to situations and to people  Problems with alcohol or drug use  Major changes in eating habits  Sex drive changes  Excessive anger, hostility or violence  Suicidal thinking
  • 5. Types of Psychiatric Disorders  Depression  Anxiety  Psychosis
  • 6.  A psychiatric disorder is a mental illness refers to a broad range of problems that disturb person's thoughts, feelings, behavior or mood.  It can significantly affect a person's ability to perform at work or school, or maintain healthy social relationships.  Psychiatric disorders are treatable.
  • 7.  Examples of psychiatric disorders are:  (1) Major depressive disorder (Depression) which is characterized by persistent low moods and loss of energy and enthusiasm.  (2) Generalized anxiety disorder (Anxiety) which is characterized by excessive, persistent, unrealistic worry about everyday things.  (3) Psychosis which is characterized by a disconnection from reality (may have hallucinations or delusions).
  • 8.  (4) Post-traumatic stress disorder which is characterized by intense, disturbing thoughts and feelings related to a traumatic experience long after the experience is over.  (5) Bipolar disorder which is characterized by extreme shifts in mood, energy, and activity level.
  • 9. DEPRESSION  Depression, also known as major depressive disorder (MDD) or clinical depression is achronic episodic and relapsing mood disorder primarily characterized by depressed or sad mood and anhedonia lasting for at least 2 weeks.  Anhedonia is an inability to feel pleasure normally pleasurable activities MDD can cause significant distress and impairment is leading cause of suicide Occurrence of MDD in females is almost twice than in males There are various subtypes of MDD characterized by additional symptoms or occurrenc in
  • 10.  (a) Atypical depression additionally characterized by weight gain and increase appetite  (b) Psychotic depression with additional psychotic features such as hallucinations an delusions  (c) Peripartum depression which occurs during or shortly after pregnancy.
  • 11. Etiopathogenesis of Depression  The etiology of depression is very complex. It includes both biological and psychological factors.  Decreased levels of monoamine neurotransmitters (serotonin, noradrenaline, dopamine) are believed to be the pathophysiological basis in most cases.  Psychological factors such as traumatic and stressful experiences and comorbidities like neurodegenerative and chronic inflammatory diseases also play important role in developing depression.  Complications of depression include self-
  • 12. Clinical Manifestations of Depression  Depression symptoms can vary from mild to severe and can include: sad mood, a feeling of deep sadness (melancholia), anhedonia, low energy, worthlessness, guilt, psychomotor retardation or agitation, change in appetite and/or sleep, increase in purposeless physical activity (e.g, hand-wringing or pacing) or slowed movements and speech, suicidal thoughts etc.  In elderly patients, memory loss and other symptoms seen in dementia may be there.
  • 13. Diagnosis and Investigation of Depression  First of all, rule out medical causes of depression and drug induced depression. Follow the DSM-5 criteria to make a diagnosis of depression DSM-5 is Diagnosis Statistical Manual of Mental Disorders, 5 Ed. Available at  https://psychiatry.org/psychiatrists/practice/ds m Use screening tools  eg. Patient Health Questionnaire PHQ9, PHQ2
  • 14. Management of Depression  Goals of Therapy  1. Resolution of all signs and symptoms of depression (i.e, remission) and restoration of functioning  Reduction of further episodes of depression (ie, relapse or recurrence).  Prevention of occurrence of new episode of depression and suicide.  Resolving residual symptoms (eg, fatigue, cognitive impairment, anhedonia, anxiety).  Restoration of occupational, psychosocial and interpersonal function
  • 15. Treatment Modalities Available:  1. Psychotherapy alone  2. Pharmacotherapy alone  3. Psychotherapy combined with pharmacological therapy Selection of treatment modality is based on following factors  1. Severity of symptoms (mild, moderate or severe)  2. Presence of other diseases (comorbidities) or psychosocial stressors  3. Preference of patient  4. History of prior treatment
  • 16.  Psychotherapy or pharmacological therapy may be used alone if patient has mild to moderate depression.  Psychotherapy combined with pharmacological therapy may be useful for patients with moderate to severe depression.
  • 17. Non-Pharmacological Management of Depression  Psychotherapy  Psychotherapy is the initial choice of treatment for mild to moderate depression.  It is also he treatment of choice for pregnant patients or those who desire pregnancy. It is given in combination with antidepressants in patients who have moderate to severe depression.  Types of psychotherapy include:
  • 18. (a) Cognitive behavioral therapy (CBT) (b) Interpersonal therapy (c) Psychodynamic psychotherapy (d) Family and couples therapy
  • 19.  (a) Cognitive-Behavioral Therapy (CBT): Cognitive behavioral therapy helps the patient to recognize negative or unhelpful thought and behavior patterns. It promotes self control over thinking patterns.  (b) Interpersonal Therapy (IPT): Interpersonal therapy aims at resolving interpersonal problems (eg, social isolation, prolonged grief, reducing stress involving family and work, improving communication skills and symptomatic recovery.
  • 20.  (c) Psychodynamic Psychotherapy: Psychodynamic psychotherapy aims at promoting personality change through understanding of major conflicts, ego distortions providing role model, permitting emotional release of aggression.  (d) Family and Couples Therapy: It is considered for patients with significant marital or family distress
  • 21. Pharmacological managements  1. The goal of pharmacotherapy of depression is the resolution of current symptoms (ie.remission) and the prevention of further episodes of depression (ie. relapse or recurrence)  2. Selection of antidepressant drugs will be based on side effect profile, prior respons history of patient or family member presence of comorbidities, concurrent medication risk of death from overdose and patient preference and cost.
  • 22.  3. Patients should be informed that adverse effects might occur immediately, whereas resolution of symptoms can take 2 to 4 weeks or longer. If side effects occur, eithe decrease the dose of the drug or shift to another antidepressant which does not cause the same adverse effect.  4. Always start with the lowest dose of drug and increase in small steps to full therapeutic dose.  5. It is recommended that antidepressant dose be increased in patients who non-improvers
  • 23. Classification of Antidepressants  Selective serotonin reuptake inhibitors (SSRIs). Health care providers often start by prescribing an SSRI. These antidepressants generally cause fewer bothersome side effects and are less likely to cause problems at higher therapeutic doses than other types of antidepressants. SSRIs include  fluoxetine (Prozac),  paroxetine (Paxil, Pexeva),  sertraline (Zoloft),  citalopram (Celexa) and  escitalopram (Lexapro).
  • 24.  Serotonin and norepinephrine reuptake inhibitors (SNRIs). Examples of SNRIs include  duloxetine (Cymbalta, Drizalma Sprinkle),  venlafaxine (Effexor XR),  desvenlafaxine (Pristiq) and  levomilnacipran (Fetzima).
  • 25.  Atypical antidepressants. These antidepressants are called atypical because they don't fit neatly into any of the other antidepressant categories. More-commonly prescribed antidepressants in this category include trazodone, mirtazapine (Remeron), vortioxetine (Trintellix), vilazodone (Viibryd) and bupropion (Forfivo XL, Wellbutrin SR, others). Bupropion is one of the few antidepressants not frequently associated with sexual side effects.
  • 26.  Tricyclic antidepressants. Tricyclic antidepressants — such as imipramine, nortriptyline (Pamelor), amitriptyline, doxepin and desipramine (Norpramin) — tend to cause more side effects than newer antidepressants. So tricyclic antidepressants generally aren't prescribed unless you've tried other antidepressants first without improvement.
  • 27.  Monoamine oxidase inhibitors (MAOIs). MAOIs — such as tranylcypromine (Parnate), phenelzine (Nardil) and isocarboxazid (Marplan) — may be prescribed, often when other medicines haven't worked. This is because they can have serious side effects. Using an MAOI requires a strict diet because of dangerous (or even deadly) interactions with foods that contain tyramine — such as certain cheeses, pickles and wines — and some medicines, including pain medicines, decongestants and certain herbal supplements. Selegiline (Emsam), an MAOI that you stick on your skin as a patch, may cause fewer side
  • 28.  Other medications. Your health care provider may recommend combining two antidepressants. Or your provider may add other medicines to improve antidepressant effects. This is called augmentation. Examples of antidepressant augmentation medicines include aripiprazole (Abilify), quetiapine (Seroquel) and lithium (Lithobid).
  • 29. Anxiety  The term anxiety has been used for decades to refer to thoughts and behaviours that were distressful in nature.  But before they referred to these as “anxiety disorders”, they are called “neurosis” which means nervousness that was not based in fact.  Anxiety can be described as a feeling of alarm or worry. It may be about something specific or it may be non-specific in nature.  At certain level it improves our performance and allow people to avoid dangerous
  • 30.  This normally lasts for a short period causing no impairment in social or occupational functioning.  When this anxiety is prolonged and affects social or occupational functioning, it is abnormal and accounts for anxiety “disorder”.
  • 31. Etiopathogenesis  Anxiety is of a greater degree than just everyday worries and patients do mention that they are not able to control these worries. They are frequently accompanied with physical symptoms as well. These symptoms have to present for most days at least for several weeks at a time.  Patients often experience a state of intense apprehension, uncertainty, and fear resulting from the anticipation of a threatening event or situation, often to a degree that normal physical and psychological functioning is disrupted. This may be precipitated due to several reasons which are generally easily identified by patient himself.
  • 32. Clinical manifestations  Feelings that something undesirable.  Dry mouth, swallowing difficulty, hoarseness.  Rapid breathing and heartbeat, palpitations.  Twitching or trembling.  Muscle tension headaches backache.  Dizziness or faintness.  Difficulty in concentrating.  Nausea, diarrhoea, weight loss.  Memory problems and difficulty in concentrating.  Sweating, fatigue, irritability.  Sleeplessness and nightmare.
  • 33. Non-pharmacological managements  Follow the diet rules and pattern because any disturbance in the digestive activity leads to the mental manifestations.  Visit the religious and graceful places and try to spending much time on that place.  Avoid the over thinking and bad habits and try to always indulges with your own work, which makes you pleasant.  Regular practice of yoga and meditation it is the most important factor for managing the psychiatric disorders.  Multimedia, internet etc. are one among the cause of the psychiatric disorder, so try to use those such things with proper time and need.
  • 34. Pharmacological Management of Anxiety  Selective serotonin reuptake inhibitors (SSRIs). Health care providers often start by prescribing an SSRI. These antidepressants generally cause fewer bothersome side effects and are less likely to cause problems at higher therapeutic doses than other types of antidepressants. SSRIs include  fluoxetine (Prozac),  paroxetine (Paxil, Pexeva),  sertraline (Zoloft),  citalopram (Celexa) and  escitalopram (Lexapro).
  • 35.  Serotonin and norepinephrine reuptake inhibitors (SNRIs). Examples of SNRIs include  duloxetine (Cymbalta, Drizalma Sprinkle),  venlafaxine (Effexor XR),  desvenlafaxine (Pristiq) and  levomilnacipran (Fetzima).
  • 36. Psychosis  Psychosis and the specific diagnosis of schizophrenia represent a major psychiatric disorder (or cluster of disorders) in which a person’s perceptions, thoughts, mood and behaviour are significantly altered.  Psychosis is a common and functionally disruptive symptom of many psychiatric, neurodevelopmental, neurologic, and medical conditions and an important target of evaluation and treatment in neurologic and psychiatric practice.
  • 37. Etiopathogenesis  A psychotic episode or disorder will result in the presence of one or more of the following five categories: delusions, hallucinations, disorganized thought, disorganized behaviour, negative symptoms.  Some common causes similar to the anxiety but is also induced as-  Genetic/heredity.  Chemical imbalances.
  • 38. Clinical manifestations  Unusual and extremely slowed movements.  Incoherent or disorganized speaking.  Hallucinations, usually related to hearing voices or strange sounds.  Delusions  Isolating behaviour.  Feeling suspicious paranoid or afraid.  Not caring about their hygiene and appearance.  Depression anxiety and suicidal thought.
  • 39. Non-pharmacological managements.  Follow the diet rules and pattern because any disturbance in the digestive activity leads to the mental manifestations.  Visit the religious and graceful places and try to spending much time on that place.  Avoid the over thinking and bad habits and try to always indulges with your own work, which makes you pleasant.  Multimedia, internet etc. are one among the cause of the psychiatric disorder, so try to use those such things with proper time and need.  Regular practice of yoga and meditation it is the most important factor for managing the psychiatric disorders.